Cargando…
Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
BACKGROUND: Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy for men-who-have-sex-with-men (MSM). The high cost of PrEP has until recently been a primary barrier to its use. In 2017, generic PrEP became available, reducing the costs by 90%. AIM: Our objective was to asse...
Autores principales: | van de Vijver, David A M C, Richter, Ann-Kathrin, Boucher, Charles A B, Gunsenheimer-Bartmeyer, Barbara, Kollan, Christian, Nichols, Brooke E, Spinner, Christoph D, Wasem, Jürgen, Schewe, Knud, Neumann, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381659/ https://www.ncbi.nlm.nih.gov/pubmed/30782266 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.7.1800398 |
Ejemplares similares
-
HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012) -
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022) -
Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study
por: Koppe, Uwe, et al.
Publicado: (2019) -
HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022) -
Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)